December 6, 2016 / 1:22 PM / 8 months ago

BRIEF-Azurrx Biopharma agrees in principle with Transchem for MTAN inhibition technology

1 Min Read

Dec 6 (Reuters) - Azurrx Biopharma Inc:

* Azurrx Biopharma announces agreement in principle with transchem for MTAN inhibition technology Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below